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Abstract 
Heme enzymes activate oxygen through formation of transient iron-oxo (ferryl) intermediates of the 
heme iron. A long-standing question has been the nature of the iron-oxygen bond and, in particular, 
the protonation state. We present neutron structures of the ferric derivative of cytochrome c 
peroxidase and its ferryl intermediate; these allow direct visualization of protonation states. We 
demonstrate that the ferryl heme is an Fe(IV)=O species and is not protonated. Comparison of the 
structures shows that the distal histidine becomes protonated on formation of the ferryl 
intermediate, which has implications for the understanding of O–O bond cleavage in heme enzymes. 
The structures highlight the advantages of neutron cryo-crystallography in probing reaction 
mechanisms and visualizing protonation states in enzyme intermediates. 
 
 
Aerobic organisms have evolved to use the intrinsic oxidizing power of oxygen from the atmosphere. 
This activation of oxygen is achieved by a catalytic metal center (usually iron or copper) buried 
within a protein. In the case of iron, high-valent iron-oxo (also known as ferryl) intermediates play a 
role in a large number of different, and sometimes difficult, biological oxidations catalyzed by 
various heme and non-heme iron-containing enzymes. 
 
For the heme iron enzymes, the mechanism of oxidation involves initial formation of the iconic 
compound I intermediate (1, 2). Compound I contains an oxidized ferryl heme, plus either a 
porphyrin π-cation radical or a protein radical; reduction of compound I by one electron yields the 
closely related compound II intermediate, which contains only the ferryl heme. These compound I 
and II intermediates are a defining feature across the heme enzyme family and appear in a diverse 
group of catalytic heme enzymes that include all the cytochrome P450s, the nitric oxide synthases, 
and the terminal oxidases, plus the heme dioxygenases and heme peroxidases. Indeed, they are such 
crucial intermediates in so many processes—including many involved in drug metabolism and other 
important oxidations—that their structure and reactivity has become a key question for both heme 
(3–7) and non heme iron enzymes where similarly transient iron-oxo species are also employed (8, 
9). 
 
A long-standing and highly contentious question has been to clarify the bond order and protonation 
state of the ferryl heme. The question has focused on whether the ferryl is formulated as an 
Fe(IV)=O [iron(IV)-oxo] or Fe(IV)-OH [iron(IV)-hydroxide] species, but there are a number of reasons 
why previous methodologies—none of which can measure the protonation state directly—have 
failed to fully resolve the issue. To begin with, even capturing these transient intermediates in some 
enzymes [especially in the P450s (10, 11)] has proved very difficult. Early approaches to the problem 
used both extended x-ray absorption fine structure and resonance Raman methods [reviewed in 
(12)] to examine the iron-oxygen bond as an indirect reporter on the protonation state. These 
studies indicate a short Fe-O bond length, but the data were not totally consistent, and the 
photolability of compound I during laser excitation is well documented (13) so that interpretation of 
stretching frequencies from Raman work has not been unambiguous either. More recently, x-ray 
crystallographic methods have been employed. These methods showed longer iron-oxygen bond 
lengths, but the x-ray structures of compounds I and II were subsequently shown to have been 
affected by photoreduction of the iron and are now considered to be unreliable. The more recent 
use of multiple crystals in x-ray analyses minimizes photoreduction but cannot entirely eliminate the 
problem. Moreover, hydrogen atoms are difficult to locate in electron density maps due to their 
weak scattering. Even if very high-resolution data (i.e., better than 1.2 Å) are available, hydrogen 
atoms can remain obscured due to their mobility. There is also the substantive question of whether 
such small changes in Fe-O bond length (<0.2 Å) between Fe(IV)=O and Fe(IV)-OH species, even if 
measured at high resolution and without photoreduction, are determined accurately enough in x-ray 
experiments to report reliably on the protonation state. 
 
For these reasons, we have adopted a different approach. Neutron diffraction offers a more reliable 
solution to the problem, because hydrogen and, particularly, its isotope deuterium (D) are visible at 
much lower resolutions than required with x-rays (14, 15). The approach does present a number of 
challenges, particularly the need to cool the large crystals required for neutron crystallography down 
to the cryogenic temperatures required for the study of enzyme intermediates (16). But the fact that 
neutrons are non-ionizing and are scattered by the atomic nuclei (rather than by the electrons, as in 
x-ray crystallography) means that photoreduction, which has been the source of most of the 
confusion in previous x-ray work, does not occur at all. In the case of redox enzymes, the elimination 
of photoreduction is a considerable advantage if the other experimental challenges can be 
overcome. 
 
In this work, we have used neutron crystallography to determine the structure of ferric cytochrome c 
peroxidase (CcP) and its transient ferryl intermediate. The structures allow us to visualize the 
positions of hydrogen and deuterium atoms in the enzyme, as well as to unambiguously identify the 
protonation state of the ferryl heme. 
 
Cytochrome c peroxidase catalyzes the H2O2-dependent oxidation of cytochrome c. Compound I of 
CcP, formed rapidly from the reaction of ferric enzyme with peroxide, contains a ferryl heme plus a 
stable protein radical on Trp191 (17). It was the first peroxidase to be crystallized (18) and over 
many years has served as a model enzyme for the understanding of oxygen activation across the 
family of catalytic heme enzymes. We first solved the neutron structure of ferric CcP to 2.4 Å at 
room temperature. The structure was determined using x-ray and neutron diffraction data obtained 
from a D2O-exchanged crystal (see supplementary materials and methods; data and refinement 
statistics are shown in table S1). 
 
Figure 1 shows nuclear scattering and electron density of ferric CcP in the region of the heme and 
summarizes the positions of all the hydrogen and deuterium atoms. On the distal side of the heme 
(Fig. 1, A and C), His52 is neutral as Nδ is deuterated but Nε is not. The Nε of Trp51 is deuterated; 
Arg48 is fully deuterated and positively charged. The neutron structure unambiguously identifies W1 
as a heavy water molecule (D2O), rather than an OD– ion, at a distance of 2.7 Å from the iron. We 
assign the heme as five-coordinate. On the proximal side (Fig. 1, B and D), Nε of His175 is not 
deuterated and is 2.0 Å from the iron. The Nδ of His175 is deuterated and within hydrogen bond 
distance of the unprotonated Oδ2 of Asp235; likewise, Oδ1 of Asp235 is unprotonated and within 
hydrogen bond distance of the deuterated Nε of Trp191. Both heme propionates are unprotonated. 
 
 
Fig. 1 
The structure of ferric CcP in the region of the heme. 
In the neutron experiment, neutrons are diffracted by the atomic nuclei (in contrast to x-rays, which 
are scattered by electrons). Hydrogen atoms (shown in magenta) have a negative coherent neutron 
scattering length (–3.74 fm), whereas deuterium atoms (shown in white) have a positive coherent 
scattering length (6.77 fm). Exchangeable hydrogen atoms, therefore, show up with density similar 
to carbon (6.65 fm) and oxygen (5.85 fm), whereas nitrogen has a greater scattering length (9.37 
fm). The scatter from a methylene (CH2) group sums to nearly zero, so that at moderate resolution 
(~2 to 2.5 Å) cancellation of nuclear scattering density is observed, and the joint refinement allows 
use of the x-ray terms to place the nonhydrogen atoms in these regions. Nuclear scattering density 
[σA-weighted 2Fo-Fc contoured at 2.6 root mean square (RMS)] in the (A) distal and (B) proximal 
heme pocket is shown in cyan. Electron density (σA-weighted 2Fo-Fc contoured at 2.4 RMS) in the 
(C) distal and (D) proximal pocket is shown in magenta. The black contour (σA-weighted neutron Fo-
Fc contoured at 5.0σ) shows the difference density calculated by omitting the bound water (W1). 
Protonation states are depicted for (E) distal and (F) proximal active site residues. The distal pocket 
shows an ordered water molecule (W1) 2.7 Å away from the five-coordinate heme iron. W1 donates 
a hydrogen bond to the π orbitals of the porphyrin ring and may be a potential hydrogen bond 
acceptor to the deuterated Nε of Trp51. W1 may also interact with a poorly ordered water (not 
shown) that displaces the guanidinium of Arg48, which is seen in the “out” position (19). Color 
scheme: hydrogen atoms, magenta; deuterium, white; oxygen, red; nitrogen, blue; carbon, yellow; 
iron, orange sphere. Hydrogen bonds are shown as dashed lines. H, His; R, Arg; D, Asp; W (except 
W1), Trp. 
 
Crystals of D2O-exchanged CcP (see supplementary materials and methods) were reacted with 
hydrogen peroxide as previously reported (19). Formation of compound I in CcP crystals is 
established [e.g., (20, 21)] but was verified in several ways. Single-crystal microspectrophotometry at 
100 K on similar (smaller) crystals showed the characteristic absorption peaks in the visible region 
(530, 560, and 632 nm) (fig. S1A), in agreement with the literature (22). Spectra of these crystals 
were unchanged on storage over 20 days (fig. S1B). Single-crystal electron paramagnetic resonance 
(EPR) on similar crystals prepared and reacted in the same way (see supplementary materials and 
methods) also showed the appearance of the characteristic g = 2 signal from the Trp191 radical (17) 
(fig. S2); in solution, compound I of CcP is stable for hours at room temperature (23) and indefinitely 
at 77 K (figs. S3 and S4). 
 
We then used x-ray and neutron diffraction data to determine the 2.5 Å resolution neutron structure 
of compound I of CcP at 100 K (see supplementary materials and methods). Figure 2 shows nuclear 
scattering and electron density in the region of the heme and summarizes the positions of all the 
hydrogen and deuterium atoms. Data and refinement statistics are shown in table S2. Nuclear 
scattering and electron density maps for individual active site residues are shown in fig. S5. In 
comparison to the ferric enzyme, most of the protonation states are retained in the compound I 
structure, with the exception of His52, which is now deuterated at both Nδ and Nε (fig. S5D). We 
observe that the Nε of the Trp191 radical is deuterated, which identifies the radical species as a 
(protonated) π-cation radical (24). Compared to the ferric enzyme, Arg48 has moved into the heme 
pocket. 
 
Fig. 2 
The structure of compound I of CcP in the region of the heme. 
Nuclear scattering density (σA-weighted 2Fo-Fc contoured at 2.2 RMS) in the (A) distal and (B) 
proximal heme pocket is shown in cyan. Electron density (σA-weighted 2Fo-Fc contoured at 2.6 RMS) 
in the (C) distal and (D) proximal heme pocket is shown in magenta. The black contour (σA-weighted 
neutron Fo-Fc contoured at 3.5σ) shows the difference density calculated by omitting the ferryl 
oxygen. Protonation states are depicted for (E) distal and (F) proximal active site residues. In the 
distal pocket, the ferryl oxygen acts as an acceptor for hydrogen bonds from the deuterated Nε of 
Arg48 and the deuterated Nε of Trp51. His52 is deuterated at both Nδ and Nε, the latter acting as a 
hydrogen bond donor to a bound water molecule (W2). W2 donates a hydrogen bond to the π 
orbitals of the porphyrin ring. Color scheme is as in Fig. 1, with the iron and ferryl oxygen depicted as 
orange and red spheres. 
 
Analysis of the nuclear scattering density maps indicates that the ferryl oxygen is not deuterated in 
the structure. This is confirmed by examination of the hydrogen bond structure: The ferryl oxygen 
acts as a hydrogen bond acceptor to the Nε of Trp51 and to the Nε of Arg48, both of which are 
accordingly deuterated. We interpret this geometry as consistent with an unprotonated Fe(IV)=O 
species. An Fo–Fc neutron map calculated in the absence of the ferryl oxygen shows a peak (3.8σ) in 
nuclear scattering density at 1.6 Å from the iron atom (Fig. 2, A and B), which is consistent with the 
most recent x-ray data [reported as 1.63 Å (19) and 1.73 Å (25)]. However, bond lengths cannot be 
determined precisely at this resolution and, as we note above, report only indirectly on the 
protonation state. The unambiguous observation from the neutron structure is that the oxygen is 
not protonated, which establishes that the ferryl intermediate is an Fe(IV)=O species at this pH. The 
neutron data show that there is no hydrogen bond from the distal histidine to the ferryl heme, as 
has been suggested previously (26) in horseradish peroxidase to account for pH-dependent 
spectroscopic behavior of the ferryl intermediate. 
 
Mechanisms for O–O bond cleavage in peroxidases are invariably drawn (1, 27) showing the distal 
histidine (His52 in the case of CcP) as neutral in both ferric and compound I species, which assumes 
that both protons of H2O2 are used in the formation of a water molecule. Our data are not 
consistent with this long-standing description. His52 is indeed neutral in the ferric state (Fig. 1 and 
fig. S5E) but is deuterated on Nε and Nδ in compound I (Fig. 2 and fig. S5D). We take this to mean 
that the widely assumed role of the distal histidine in compound I formation—acting first as a base 
catalyst (to deprotonate peroxide) and then as an acid catalyst (to protonate the peroxide oxygen 
and release water)—needs to be reassessed. 
 
Possible alternative mechanisms showing movement of protons during O–O bond cleavage are 
shown in Fig. 3. Ferric CcP is unprotonated on the Nε of His52, and the Nε lone-pair geometry does 
not interact ideally with any neighboring proton donors. This lack of ideal hydrogen bonding 
structure in the ferric form may favor formation of the peroxide complex and the deprotonated 
compound 0 (28), as structures of the closely related compound III (oxy) complexes all suggest that 
more favorable hydrogen bonding interactions with the bound peroxide are likely (fig. S6). Our data 
suggest that His52 retains a proton upon formation of compound I. In terms of proton count, this 
presumably means that delivery of an additional proton to compound 0 is needed for compound I 
formation if water is released as product (Fig. 3A), aligning the mechanism more closely with the 
related P450s in which delivery of a single proton to compound 0 is also widely assumed (2, 29). 
Arg48, which is protonated (Figs. 1 and 2), could act as the source of the additional proton required 
for release of water in both formation and reduction of compound I, as it is thought to play a role in 
proton-relay networks (30). Hydroxide (instead of water, Fig. 3A) formation is also possible; if this is 
the case, a role for Arg48 in charge stabilization of OH– is easily envisaged and would be consistent 
with early predictions (31). Because the proton on His52 must be removed before a second turnover 
of the enzyme can occur, the acid-catalysis role of His52 must occur after compound I formation and 
not [as is often assumed (1)] before (Fig. 3A). An alternative and intriguing possibility (Fig. 3B), which 
could apply generally to any heme protein with a distal histidine in the heme pocket, is that O–O 
bond cleavage initially forms a transient Fe(IV)-OH species [as in the P450s (32)], but the presence of 
the distal histidine provides an escape route for the proton, thus disfavoring formation of Fe(IV)-OH. 
Proton transfer in this direction, to form Fe(IV)=O, would be consistent with published pKas (Ka, acid 
dissociation constant) for the distal histidine across the peroxidase family [estimated pKa ≈ 4 to 5 (1, 
33)] if the pKa of the ferryl heme, which is not known reliably for a heme peroxidase, was lower than 
that. 
 
Fig. 3 
Possible movement of protons during O–O bond activation. 
(A) Formation of a peroxide-bound complex and then compound 0 is followed by O–O bond 
cleavage. The distal histidine retains a proton upon formation of compound I, which means that an 
additional proton is required for release of water in both formation and reduction of compound I. 
(See text for detailed discussion.) The orientation of deuterium atoms on active site water molecules 
(Figs. 2 and 3) seems to preclude a water-mediated mechanism for O–O bond cleavage as suggested 
in horseradish peroxidase (34) because the deuterium atoms on W2 are oriented away from the 
ferryl oxygen atom and a hydrogen bond would not be possible (Fig. 2E). (B) An alternative 
mechanism from the same peroxide-bound complex. Cleavage of the peroxide bond may lead 
initially to formation of a transient iron(IV)-hydroxide species [Fe(IV)-OH], which, via proton transfer, 
leads to compound I, with Fe(IV)=O and a protonated distal histidine. 
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